10.13.22
The California Biomanufacturing Center (CBC) has launched the BioProcess to Product (BioP2P) Network, a program to accelerate the transformation of manufacturing in the United States for the growing bioeconomy.
CBC recognizes the challenges facing this growing sector in bringing products from the lab to commercial scale. Its BioP2P Network will engage the industry broadly to work together to tackle these challenges.
CBC was established in 2020 as a public-private partnership of companies, workforce, and government agencies supporting the growth of biomanufacturing as a high-value, strategic sector. The leadership at CBC has been engaged in the bioeconomy for more than two decades dating back to first-generation industrial enzymes to the current new generation of precision fermentation.
Schmidt Futures, a philanthropic initiative founded by Eric and Wendy, is supporting the BioP2P Network. CBC is using the Schmidt Futures grant to bring together stakeholders across the United States to foster scale-up for non-biomedical technology developers across the country to move from pilot to commercial production.
The support comes on the heels of the Biden Administration unveiling its national biomanufacturing initiative, signaling major investment to drive research and development, grow capacity, and expand market opportunities. It also follows a $13 billion surge in new investment in the bioeconomy in 2021.
“As we’ve seen with the Biden Administration’s initiative, Schmidt Futures is creating a national discussion about the emerging bioeconomy and the need for the United States to lead the way forward,” said Matt Gardner, founder and chair of the California Biomanufacturing Center. “A new generation of companies are seeking to harness biology to create clean and cost-effective production facilities. This grant will give CBC the resources necessary to help biomanufacturers navigate the path from pilot to commercial-scale manufacturing.”
The BioP2P Network will begin meeting this month to help companies identify scale-up processor capacity around the country that is available to them.
CBC recognizes the challenges facing this growing sector in bringing products from the lab to commercial scale. Its BioP2P Network will engage the industry broadly to work together to tackle these challenges.
CBC was established in 2020 as a public-private partnership of companies, workforce, and government agencies supporting the growth of biomanufacturing as a high-value, strategic sector. The leadership at CBC has been engaged in the bioeconomy for more than two decades dating back to first-generation industrial enzymes to the current new generation of precision fermentation.
Schmidt Futures, a philanthropic initiative founded by Eric and Wendy, is supporting the BioP2P Network. CBC is using the Schmidt Futures grant to bring together stakeholders across the United States to foster scale-up for non-biomedical technology developers across the country to move from pilot to commercial production.
The support comes on the heels of the Biden Administration unveiling its national biomanufacturing initiative, signaling major investment to drive research and development, grow capacity, and expand market opportunities. It also follows a $13 billion surge in new investment in the bioeconomy in 2021.
Creating a National Inventory of Validated, Scale-Up Facilities
An initial priority for the BioP2P Network will be to create a national inventory of validated, scale-up facilities. This open-access inventory of facilities will allow developers to readily partner. The BioP2P network will serve as a first-of-its-kind marketplace for these interactions to flourish.“As we’ve seen with the Biden Administration’s initiative, Schmidt Futures is creating a national discussion about the emerging bioeconomy and the need for the United States to lead the way forward,” said Matt Gardner, founder and chair of the California Biomanufacturing Center. “A new generation of companies are seeking to harness biology to create clean and cost-effective production facilities. This grant will give CBC the resources necessary to help biomanufacturers navigate the path from pilot to commercial-scale manufacturing.”
The BioP2P Network will begin meeting this month to help companies identify scale-up processor capacity around the country that is available to them.